Today: November 19, 2018 5:41 am
Location Kit

Tag: Novartis


A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
October 28, 2018

The 2-year knowledge for Novartis brolucizumab reaffirm the prevalence to aflibercept in fluid discount in sufferers with DMN

HANOVER DEL ESTE, N.J., October 27, 2018 / PRNewswire / – Novartis declares further outcomes of second section brolucizumab Part III that reaffirmed optimistic first 12 months outcomes. Brolucizumab places its main endpoint of noninferiority to aflibercept in one of the best corrected visible acuity (MCVA) and confirmed a superiority in the important thing retinal ends in one (48 weeks)1.2. The secondary endpoints in two years (96 weeks) reaffirmed the prevalence of brolucizumab 6 mg within the discount of retinal fluid, an vital marker of illness exercise in sufferers with age-related macular...

Continue Reading
Share